Akèy › Gliyoblastòm › Ohio › Cleveland
Etid klinik pou Gliyoblastòm nan Cleveland, OH
11 etid pou Gliyoblastòm ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Ap rekriteFaz 2/3
- University Hospitals Cleveland Medical Center*, Cleveland
- Cleveland Clinic, Cleveland
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
Ap rekriteFaz 3
- Neurological Institute Brain Tumor Centre Taussig Cancer Cente, Cleveland
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Ap rekriteFaz 2
- Cleveland Clinic Taussig Cancer Center, Cleveland
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Ap rekriteFaz 3
- Case Western Reserve University, Cleveland
hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
Ap rekriteFaz 2
- University Hospitals Cleveland Medical Center, Cleveland
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Ap rekriteFaz 3
- Cleveland Clinic, Cleveland
Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
Ap rekriteFaz 1
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Ap rekriteFaz 2
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Sacituzumab Govitecan in Recurrent Glioblastoma
Ap rekriteFaz 2
- Cleveland Clinic Taussig Cancer Center, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi lwen
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Ap rekriteFaz 1
- The Cleveland Clinic, Cleveland
Etid Gliyoblastòm nan lòt vil
- New York City, NY30 etid
- Boston, MA28 etid
- Houston, TX25 etid
- Los Angeles, CA23 etid
- Durham, NC20 etid
- San Francisco, CA17 etid
- Washington, DC15 etid
- Chicago, IL15 etid
- Rochester, MN15 etid
- Columbus, OH14 etid
- Miami, FL14 etid
- Jacksonville, FL13 etid
Lòt etid nan Cleveland
- Kansè Poumon ki pa ti selil43 etid
- Kansè (tout kalite)36 etid
- Kansè nan tete35 etid
- Kansè pwostat34 etid
- Ensifizyans kadyak33 etid
- Kansè Metastatik30 etid
- Kansè ovè30 etid
- Kansè poumon26 etid
- Kansè kolorektal24 etid
- Maladi kadyovaskilè22 etid
- Kansè Endomèt20 etid
- Leksemi mieloïd egi20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.